Loading...
The Financial Express

India approves Covid-19 nasal vaccine for restricted use

| Updated: September 14, 2022 22:01:55


-Reuters file photo -Reuters file photo

India has approved a recombinant nasal vaccine, developed by Indian multinational biotechnology company Bharat Biotech to combat Covid-19.

The country's Health Minister Mansukh Mandaviya gave the information in a tweet on Tuesday, reports Reuters.

The Indian regulator approved the vaccine for primary immunisation of those aged 18 years and above, for restricted use in emergency situations, Mandaviya added.

Share if you like